FDA FOIA Request

An FDA FOIA request is a written request filed under the federal Freedom of Information Act (5 U.S.C. SS 552) and FDA’s implementing regulation, 21 CFR Part 20, asking FDA’s Division of Freedom of Information to release records the agency holds but has not otherwise made public. For research administrators and regulatory-intelligence staff, this is the standard route to documents that the free, public FDA Inspection Classification Database does not contain: the narrative text of a Form FDA-483, the fuller Establishment Inspection Report (EIR) behind it, a facility’s warning letters, correspondence tied to a specific IND/NDA/BLA, or portions of an approval package not already posted in FDA’s Drug/Biologic/Device Approvals databases.

What makes a request an “FDA FOIA request” specifically

Any of the following makes a records request an operational FDA FOIA request rather than a simple database lookup:

• It is submitted in writing (FDA’s online portal, mail, or fax) to FDA’s Division of Freedom of Information, not searched on a public FDA web tool.
• It asks for records FDA has not already published in a proactive disclosure channel — FDA calls its collection of already-released, frequently requested material the FOIA Electronic Reading Room, and checking it first is the standard first step before filing, since records already posted there are available immediately with no request needed.
• It is logged, assigned a tracking number, and processed under the statutory and regulatory timeline in 21 CFR Part 20 (see below), including FDA’s own fee schedule and requester-category rules under that Part.
• Center-specific variants exist — for example, device-related records can be requested through CDRH’s own FOIA channel — but all are administered under the same Part 20 framework and the same Division of Freedom of Information for cross-center or headquarters-held records.

How to file

FDA’s preferred channel is its online submission portal (linked from FDA’s “How to Make a FOIA Request” page) or FOIA.gov; requests can also be mailed to the Division of Headquarters Freedom of Information, 5630 Fishers Lane, Room 1035, Rockville, MD 20857. A compliant request must be in writing and include the requester’s name, mailing address, phone/email, a reasonably specific description of the records sought (facility name, date range, application number, or inspection date, where known), and a statement of willingness to pay applicable fees or a fee-waiver justification.

Statutory timeline versus practical reality

Under 21 CFR Part 20.40, FDA is required to send a determination letter — stating whether, and to what extent, it will comply — within 20 working days of a request being logged in at the Division of Freedom of Information (excluding weekends and federal holidays), the same 20-working-day baseline the general federal FOIA statute sets for agencies. That determination letter is not the same as receiving the actual records: it typically only confirms the request has been accepted and processed for search, and complex requests are routinely placed in a multi-track queue with no fixed delivery date attached to the determination itself.

Actual delivery of records frequently takes much longer than the 20-working-day determination window, particularly for inspection-related records (483s, EIRs, warning-letter backup files) that require redaction review before release. Requesters should plan for a range measured in months, not weeks, for anything beyond a simple, already-processed record, and should expect FDA to request narrowing of an overly broad request rather than to search and produce it as originally scoped.

Fees and requester categories

21 CFR Part 20 sets FDA’s own fee schedule and defines requester categories (e.g., commercial-use requester, representative of the news media, educational/noncommercial-scientific-institution requester) that determine which fee components — search time, review time, duplication — apply and whether a fee waiver or reduction can be requested. A commercial or competitive-intelligence request (the most common use case for pulling a competitor’s or partner’s inspection history) is typically billed for search, review, and duplication in full, unlike requests that qualify for a more favorable category.

Examples

• A sponsor’s regulatory affairs team files an FDA FOIA request for the full, redacted Form FDA-483 and Establishment Inspection Report from a recent inspection at a contract manufacturing organization it is evaluating as a supplier — the public Inspection Classification Database tells them only that the inspection closed OAI, not what the specific observations were.
• A CRO’s competitive-intelligence function files a request for warning letters issued to a named competitor’s clinical sites over a defined date range, to benchmark that competitor’s inspection history ahead of a bid.

Counter-example

Searching the public FDA Inspection Classification Database or the FDA Inspections Data Dashboard for a facility’s NAI/VAI/OAI classification is not an FDA FOIA request — no written request is filed, no determination letter is issued, and no fee applies, because that data is already proactively published. A FOIA request is only necessary once the classification search doesn’t answer the question and the narrative inspection record itself is needed.

Related terms

See FDA Form 483, FDA Inspection Database, and Inspection Readiness for the surrounding inspection-documentation lifecycle this request process sits within.